S-S1
BMT Tandem Luncheon Symposium: Risk-Stratification and Management of Multiple Myeloma: The Multidisciplinary Team Approach in Managing Patients

Track: BMT Tandem "Scientific" Meeting
Wednesday, February 26, 2014: 12:30 PM-1:30 PM
Texas B+D (Gaylord Texan)
Chair:
Sergio Giralt, MD

Disclosures:
S. Giralt, Celgene, Consulting, Speaker: Consulting Fee and Honoraria
Medscape, Millennium, Speaker: Honoraria
Onyx, Sanofi, Seattle Genetics, Spectrum Pharmaceuticals, Consulting: Honoraria

Summary:

Supported by independent educational grants from Celgene Corporation, Millennium: The Takeda Oncology Company, and Onyx Pharmaceutials

Strategies to Accurately Risk-stratify Multiple Myeloma Patients
Sergio Giralt, MD, Memorial Sloan-Kettering Cancer Center

Audio File Recorded Presentation
Goals of Induction Therapy in Multiple Myeloma Transplant Candidates and Treatment-associated Side Effects
Beth Faiman, PhDc, RN, MSN, Cleveland Clinic

Audio File Recorded Presentation
Current Treatment Approaches for Relapsed/Refractory Disease
David H. Vesole, MD, PhD, Hackensack University Medical Center

Audio File Recorded Presentation
Practice Management Strategies for Dosing and Drug Administration in Multiple Myeloma
R. Donald Harvey, PharmD, Emory University Hospital

Audio File Recorded Presentation
See more of: BMT Tandem "Scientific" Meeting
<< Previous Session | Next Session >>